Sorrento Therapeutics CEO: Start of human trials for our coronavirus drug are 'two to three months away'

Sorrento Therapeutics CEO Henry Ji joined CNBC's Jim Cramer on Monday to discuss the company's progress on its efforts to develop a drug for Covid-19.